Keyword: Merck Serono

News

Germany’s Merck Adds Israeli R&D Partners

27.11.2013 - German chemicals and pharmaceutical group Merck KGaA has added two new partners, the newly created Metabomed and the start-up ChanBio, to its €10 million Merck Serono Israel...

News

Merck Serono and Selvita in Oncology R&D Pact

28.10.2013 - Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, has agreed an oncology research pact with Polish biotech company Selvita. The aim of the collaboration is to...

News

Merck KGaA Names James Stewart Chief Information Officer

30.08.2013 - German chemicals and pharmaceuticals producer Merck KGaA has appointed James Stewart as its new chief information officer, succeeding Frédéric Wohlwend, who the company said has...

News

Merck Serono Establishes Immunotherapy Platform

28.06.2013 - Merck Serono, the biopharmaceutical division of Germany-based Merck KGaA, has created a dedicated immune-oncology innovation platform integrating research, early development and...

News

After Tech Success, Israel Seeks Life Sciences Growth

06.06.2013 - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...

News

Maturing Belgian Biotechs Outshine European Peers

04.10.2012 - From its base in a business park outside the city of Ghent, Belgium's biotech industry is attracting a global following, benefiting from years of patient investment, promising...

News

Merck Serono Sets Up Biotech Incubator in Israel

15.04.2012 - Merck Serono, the biopharmaceutical division of German drugs and chemicals group Merck KGaA, inaugurated on Sunday a biotech incubator at Inter-Lab, its research and development...

News

Merck KGaA Eyes Job Cuts at Drugs Unit

12.04.2011 - Germany's Merck KGaA is mulling job cuts at prescription drug unit Merck Serono to save costs, the Financial Times Deutschland newspaper reported, citing company sources. Cutbacks...